Company Overview
NEXVITA at a Glance
A MedTech company advancing the next generation of blood pressure measurement.
"NEXVITA 是一家專注於血壓量測技術創新的醫療科技公司，致力於打造下一世代的血壓監測技術。"
Founded
NEXVITA was founded to redefine blood pressure monitoring through advanced sensor technology.
National Development Fund
NEXVITA was founded to redefine blood pressure monitoring through advanced sensor technology.
Clinical Validation
198 Patient Study
Clinical validation conducted National Cheng Kung University Hospital
NEXVITA at a Glance
NEXVITA received the 20th National Innovation Award, recognizing the company’s breakthrough technology in blood pressure measurement.
NEXVITA 榮 獲 第20屆國家新創獎，肯定公司在血壓量測技術上的創新突破。
康邁醫學科技成立於2018年六月，歷經四次天使輪獲得新台幣9,582萬元資本。現 今有九位員工，以研發人員為主。康邁醫學三位共同創辦人是林昆儀、蔡沛原與簡基城博士。
Investment & Award
2019 National Development Fund
Government-backed investment supporting medical innovation.
2019年獲得國發基金投資
2023 National Innovation Award
Winner of the 20th National Innovation Award
2023年獲得第20屆國家新創獎
Product Development
• Completion of FDA Q-Submission
"已完成 FDA Q-Submission"
• Upcoming multi-disease clinical trials
"即將展開多疾病族群臨床試驗"
• Preparation for product commercialization
"產品商業化準備中"
Leadership Team
Building the Future of Blood Pressure Technology
Built by experts across medicine, engineering, and global diagnostics.
"共同打造下一世代血壓量測技術團隊由醫學、工程與全球醫療產業專家共同組成。"
CEO
林昆儀
A MedTech entrepreneur with a proven track record in global go-to-market strategy for diagnostic technologies, including blood pressure systems. Kalex has always focused on understanding market needs and is committed to establishing and fulfilling those needs. Since 2011, when it began developing Korotkoff sound technology, until founding NEXVITA in 2018, the company has invested all its efforts into perfecting Korotkoff sound technology and bringing it to the world.
CTO
蔡沛原
A veteran biomedical engineer specializing in sensor systems, embedded electronics, and scalable device architecture. Paul has led the design and integration of product innovation and hardware-software optimization.
CSO & CMO
簡基城 博士
An experienced clinician/doctor with extensive clinical practice, who is also a successful entrepreneur, possessing a wealth of knowledge and a solid industry foundation.
Chief Medical Regulatory Affairs
張燕妮 博士
Yenni Chang, Director of Regulatory Affairs – With her 16years of expertise in FDA, CE, and Asian medical device regulations, Yenni leads NEXVITA medical device regulatory affairs and clinical study design.